{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-006478","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.629777+00:00","generated_at":"2026-05-26T22:22:11.511669+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"INBS Q2 FY2025 revenue falls 20% YoY; net loss widens to $2.26M; gross margin up 11pts","bullets":["Revenue $607,494, down 20% YoY; net loss $2.25M vs $1.97M.","Gross margin for six months improved to 38.5% from 27.7% on higher cartridge sales.","FDA 510(k) submitted in Dec 2024; planning US market entry in 2025.","Cash $2.24M; equity $4.20M as of Dec 31, 2024.","Added 19 accounts; total 400+ active accounts in 19 countries."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-006478","json":"https://secwatch.observer/filing/0001493152-25-006478.json","markdown":"https://secwatch.observer/filing/0001493152-25-006478.md","text":"https://secwatch.observer/filing/0001493152-25-006478.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225006478/0001493152-25-006478-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225006478/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:22:11.511669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}